CorMedix Inc.
NASDAQCorMedix enters the final stretch before its November 11 earnings with a rare combination: short interest still running at a structurally elevated level, yet shorts themselves are quietly trimming, even as options traders push defensive positioning to a near-52-week extreme. The short-side picture is a study in gradual retreat. Twenty percent of the free float is still short — a…
CRMD SI utilization surges to 97.1%, near 52-week peak of 100%, as borrowing demand intensifies despite 8% monthly decline in short interest.
CorMedix enters the final stretch before its November 11 earnings with a rare combination: short interest still running at a structurally elevated level, yet shorts themselves are quietly trimming, even as options…
CorMedix reports its next earnings event on August 13, and the setup is defined by one uncomfortable tension: short sellers have built a substantial position in a stock down 16% over the past month, yet options traders…
Snapshot as of 30 Sept 2026
CorMedix heads into July with a stubborn short base, a stock down nearly 9% on the week, and an August earnings date that is moving from background noise to front-of-mind. The short side of the ledger is the defining…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CRMD — free to start on ORTEX.
Sign up for free →Open CRMD on ORTEX